View source for OneFul Health, Inc. (20240269951). ADDITIVE MANUFACTURING METHOD AND APPARATUS FOR INDIVIDUALIZED POLYPILL CAPSULES USING MICRO-DOSED AND COMPACTED POWDERS simplified abstract

=ADDITIVE MANUFACTURING METHOD AND APPARATUS FOR INDIVIDUALIZED POLYPILL CAPSULES USING MICRO-DOSED AND COMPACTED POWDERS=


==Organization Name==

[[:Category:OneFul Health, Inc.|OneFul Health, Inc.]]


[[Category:OneFul Health, Inc.]]

==Inventor(s)==

[[:Category:Edison Thurman Hudson, Jr. of Chapel Hill NC (US)|Edison Thurman Hudson, Jr. of Chapel Hill NC (US)]][[Category:Edison Thurman Hudson, Jr. of Chapel Hill NC (US)]]

==ADDITIVE MANUFACTURING METHOD AND APPARATUS FOR INDIVIDUALIZED POLYPILL CAPSULES USING MICRO-DOSED AND COMPACTED POWDERS - A simplified explanation of the abstract==


This abstract first appeared for US patent application 20240269951 titled 'ADDITIVE MANUFACTURING METHOD AND APPARATUS FOR INDIVIDUALIZED POLYPILL CAPSULES USING MICRO-DOSED AND COMPACTED POWDERS

'''Simplified Explanation:'''
This patent application describes a method and apparatus for additive manufacturing of personalized oral therapeutic capsules, also known as a personalized polypill process. The process enables the creation of individualized medication forms containing multiple medicinal ingredients to address the specific medical needs of a patient.

'''Key Features and Innovation:'''
* Additive manufacturing of personalized oral therapeutic capsules
* Creation of individualized medication forms containing multiple medicinal ingredients
* Application of powder forms of active pharmaceuticals, dietary supplements, and specialized chemicals
* Deposition of computer-controlled amounts of high-potency powder forms of active ingredients in sequential layers
* Programmable dosage accuracy with closed-loop gravimetric sensing
* Compaction of cumulative doses into segregated layers of programmable density
* Optional addition of an inert barrier film between each chemical entity to minimize interactions

'''Potential Applications:'''
This technology can be used in personalized medicine, pharmaceutical manufacturing, and compounding pharmacies.

'''Problems Solved:'''
This technology addresses the challenge of creating personalized medication forms containing multiple medicinal ingredients in a precise and controlled manner.

'''Benefits:'''
The benefits of this technology include improved medication adherence, personalized treatment plans, and enhanced therapeutic outcomes for patients.

'''Commercial Applications:'''
The commercial applications of this technology include personalized medicine services, pharmaceutical manufacturing equipment, and compounding pharmacy solutions.

'''Prior Art:'''
Prior art related to this technology may include research on additive manufacturing in pharmaceuticals, personalized medicine, and precision dosing technologies.

'''Frequently Updated Research:'''
Researchers are continually exploring advancements in additive manufacturing techniques for pharmaceutical applications and personalized medicine.

'''Questions about Personalized Polypill Process:'''
1. How does the personalized polypill process improve medication adherence and therapeutic outcomes?
2. What are the potential challenges in implementing the personalized polypill process in clinical practice?


==Original Abstract Submitted==

a method and apparatus enabling additive manufacturing of individualized oral therapeutic capsule forms containing multiple medicinal ingredients, also referred to as a personalized polypill process. a process and supporting apparatus to fulfil the formulated therapy prescribed by a physician to address the medical conditions of an individual patient, furthering the practice of personalized medicine. the methods and apparatus apply to the powder forms of active pharmaceuticals, dietary supplements, and specialized chemicals, such as diagnostic inks and dyes. the methods teach the deposition of computer-controlled amounts of high-potency powder forms of active ingredients deposited in sequential layers into a single delivery form. each active ingredient layer is sequentially deposited to a programmable dosage accurately controlled with closed-loop gravimetric sensing, enabling sub-milligram mass deposition accuracy. cumulative doses are compacted into segregated layers of programmable density with the optional addition of an inert barrier film between each chemical entity to minimize interactions.



[[Category:B30B15/30]]
[[Category:B33Y30/00]]
[[Category:B33Y50/02]]
[[Category:CPC_B30B15/302]]